comparemela.com

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

Related Keywords

California ,United States ,Los Angeles ,Judith Currier ,Timothy Wilkin ,Emily Henderson ,University Of California ,Technologies Inc ,National Institutes Of Health ,National Institute Of Allergy ,Clinical Trials Group ,Drug Administration ,Trials Group ,Human Monkeypox Virus ,Weill Cornell ,National Institute ,Infectious Diseases ,National Institutes ,Monkeypox ,Kids ,Breastfeeding ,Children ,Covid 19 ,Drugs ,Efficacy ,Shiv ,Medicine ,Placebo ,Research ,Skin ,Virus ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.